Administration of Remicade using a top-down approach was superior to step-up therapy in achieving clinical remission in children with Crohn’s disease, according to research from Digestive Disease Week.Maria Jongsma, MD, from the department of pediatric gastroenterology at Erasmus University Medical Center in the Netherlands, said in a recorded audio presentation that Remicade (infliximab, Janssen) can be effective for the control of inflammatory activity in these patients, but it is often reserved for refractory patients or those who are steroid dependent.“The ultimate goal ofRead More